DUBLIN--(BUSINESS WIRE)--Aug 8, 2018--The "Molecular Cytogenetics Market by Offering, by Technology, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014 - 2023" report has been added to ResearchAndMarkets.com's offering.

Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023.

The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal abnormalities.

Based on offering, the molecular cytogenetics market has been categorized into consumables, software and services and instruments. Globally, the market for software and services is expected to register fastest growth, with CAGR of 10.5% during the forecast period. This can be attributed to rapid adoption of automation in laboratory process and rising preference for outsourcing of expensive services.

Based on technology, the molecular cytogenetics market has been categorized into comparative genomic hybridization (CGH), fluorescence in-situ hybridization (FISH), immunohistochemistry, karyotyping and others. The karyotyping technology market for molecular cytogenetics is further categorized into spectral and virtual. In 2017, spectral karyotyping held larger share, of 66.0%, in molecular cytogenetics market, owing to the usage of these technique for the detection of complex chromosomal aberration as well as for identification of new leukaemia subgroups.

During the forecast period, the molecular cytogenetics market is expected to witness fastest growth in personalized medicine application, at a CAGR of 10.1%. This growth is attributable to rise in demand for precision medicine coupled with high investments in research and development.

Based on end user, the molecular cytogenetics market has been classified into clinical and research laboratories, academic research institutes, hospitals and pathology laboratories and pharmaceutical and biotechnology companies. Among these, clinical and research laboratories held the largest share as an end-user category during the historical period in this market and accounted for a 33.4% share in 2017.

Key Highlights

Molecular cytogenetics market to witness fastest growth in Asia-Pacific (APAC) Market players are focusing on developing technologically advanced molecular cytogenetics products

Key Topics Covered

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction

Chapter 5. Global Market Size & Forecast

Chapter 6. North America Market Size & Forecast

Chapter 7. Europe Market Size & Forecast

Chapter 8. APAC Market Size & Forecast

Chapter 9. LATAM Market Size & Forecast

Chapter 10. MEA Market Size & Forecast

Chapter 11. Global Strategic Developments

Chapter 12. Company Profiles

Abbott Laboratories Danaher Corporation Bio-Rad Laboratories Inc. F. Hoffmann La-Roche AG Agilent Technologies Inc. Perkinelmer Inc. Illumina Inc. Quest Diagnostics Inc. Neogenomics Inc.

For more information about this report visit https://www.researchandmarkets.com/research/kx9p58/the_global_market?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180808005532/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/08/2018 11:36 AM/DISC: 08/08/2018 11:35 AM

http://www.businesswire.com/news/home/20180808005532/en